메뉴 건너뛰기




Volumn , Issue , 2013, Pages 449-458

Molecular evolution of leukemia stem cells

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84896309767     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-7696-2_33     Document Type: Chapter
Times cited : (3)

References (126)
  • 1
    • 0037388204 scopus 로고    scopus 로고
    • Prospective identification of tumorigenic breast cancer cells
    • Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983-8.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , Issue.7 , pp. 3983-3988
    • Al-hajj, M.1    Wicha, M.S.2    Benito-hernandez, A.3
  • 2
    • 9244241576 scopus 로고    scopus 로고
    • Identification of human brain tumour initiating cells
    • Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396-401.
    • (2004) Nature , vol.432 , Issue.7015 , pp. 396-401
    • Singh, S.K.1    Hawkins, C.2    Clarke, I.D.3
  • 3
    • 33846100356 scopus 로고    scopus 로고
    • A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
    • O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123):106-10.
    • (2007) Nature , vol.445 , Issue.7123 , pp. 106-110
    • O'Brien, C.A.1    Pollett, A.2    Gallinger, S.3    Dick, J.E.4
  • 4
    • 34547193404 scopus 로고    scopus 로고
    • Phenotypic characterization of human colorectal cancer stem cells
    • Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007;104(24):10158-63.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , Issue.24 , pp. 10158-10163
    • Dalerba, P.1    Dylla, S.J.2    Park, I.K.3
  • 5
    • 33845317573 scopus 로고    scopus 로고
    • Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
    • Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756-60.
    • (2006) Nature , vol.444 , Issue.7120 , pp. 756-760
    • Bao, S.1    Wu, Q.2    McLendon, R.E.3
  • 6
    • 33847052127 scopus 로고    scopus 로고
    • Identification of pancreatic cancer stem cells
    • Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030-7.
    • (2007) Cancer Res , vol.67 , Issue.3 , pp. 1030-1037
    • Li, C.1    Heidt, D.G.2    Dalerba, P.3
  • 7
    • 33846512398 scopus 로고    scopus 로고
    • Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
    • Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007;104(3):973-8.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , Issue.3 , pp. 973-978
    • Prince, M.E.1    Sivanandan, R.2    Kaczorowski, A.3
  • 8
    • 38349183668 scopus 로고    scopus 로고
    • Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia
    • Hong D, Gupta R, Ancliff P, et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science. 2008;319(5861):336-9.
    • (2008) Science , vol.319 , Issue.5861 , pp. 336-339
    • Hong, D.1    Gupta, R.2    Ancliff, P.3
  • 9
    • 3943088431 scopus 로고    scopus 로고
    • Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
    • Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351(7):657-67.
    • (2004) N Engl J Med , vol.351 , Issue.7 , pp. 657-667
    • Jamieson, C.H.1    Ailles, L.E.2    Dylla, S.J.3
  • 11
    • 39149086121 scopus 로고    scopus 로고
    • Stems cells and the pathways to aging and cancer
    • Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell. 2008;132(4):681-96.
    • (2008) Cell , vol.132 , Issue.4 , pp. 681-696
    • Rossi, D.J.1    Jamieson, C.H.2    Weissman, I.L.3
  • 12
    • 56349149675 scopus 로고    scopus 로고
    • Miscreant myeloproliferative disorder stem cells
    • Jamieson CH, Barroga CF, Vainchenker WP. Miscreant myeloproliferative disorder stem cells. Leukemia. 2008;22(11):2011-9.
    • (2008) Leukemia , vol.22 , Issue.11 , pp. 2011-2019
    • Jamieson, C.H.1    Barroga, C.F.2    Vainchenker, W.P.3
  • 13
    • 0017785769 scopus 로고
    • Primary bioassay of human tumor stem cells
    • Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science. 1977;197(4302):461-3.
    • (1977) Science , vol.197 , Issue.4302 , pp. 461-463
    • Hamburger, A.W.1    Salmon, S.E.2
  • 15
    • 33746498580 scopus 로고    scopus 로고
    • Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
    • Krivtsov AV, Twomey D, Feng Z, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006;442(7104):818-22.
    • (2006) Nature , vol.442 , Issue.7104 , pp. 818-822
    • Krivtsov, A.V.1    Twomey, D.2    Feng, Z.3
  • 16
    • 0030789242 scopus 로고    scopus 로고
    • Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
    • Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730-7.
    • (1997) Nat Med , vol.3 , Issue.7 , pp. 730-737
    • Bonnet, D.1    Dick, J.E.2
  • 17
    • 0030988803 scopus 로고    scopus 로고
    • Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo
    • Blair A, Hogge DE, Ailles LE, et al. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood. 1997;89(9):3104-12.
    • (1997) Blood , vol.89 , Issue.9 , pp. 3104-3112
    • Blair, A.1    Hogge, D.E.2    Ailles, L.E.3
  • 18
    • 62649139996 scopus 로고    scopus 로고
    • Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation
    • Abrahamsson AE, Geron I, Gotlib J, et al. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Proc Natl Acad Sci U S A. 2009;106(10):3925-9.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , Issue.10 , pp. 3925-3929
    • Abrahamsson, A.E.1    Geron, I.2    Gotlib, J.3
  • 19
    • 80052468964 scopus 로고    scopus 로고
    • Stem cell gene expression programs influence clinical outcome in human leukemia
    • Eppert K, Takenaka K, Lechman ER, et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med. 2011;17(9):1086-93.
    • (2011) Nat Med , vol.17 , Issue.9 , pp. 1086-1093
    • Eppert, K.1    Takenaka, K.2    Lechman, E.R.3
  • 20
    • 84859854912 scopus 로고    scopus 로고
    • A clinically relevant population of leukemic CD34+ CD38-cells in acute myeloid leukemia
    • Gerber JM, Smith BD, Ngwang B, et al. A clinically relevant population of leukemic CD34+ CD38-cells in acute myeloid leukemia. Blood. 2012;119:3571-7.
    • (2012) Blood , vol.119 , pp. 3571-3577
    • Gerber, J.M.1    Smith, B.D.2    Ngwang, B.3
  • 21
    • 0028091194 scopus 로고
    • A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
    • Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367(6464):645-8.
    • (1994) Nature , vol.367 , Issue.6464 , pp. 645-648
    • Lapidot, T.1    Sirard, C.2    Vormoor, J.3
  • 22
    • 0037059012 scopus 로고    scopus 로고
    • Preferential induction of apoptosis for primary human leukemic stem cells
    • Guzman ML, Swiderski CF, Howard DS, et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci U S A. 2002;99(25):16220-5.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , Issue.25 , pp. 16220-16225
    • Guzman, M.L.1    Swiderski, C.F.2    Howard, D.S.3
  • 23
    • 42949104680 scopus 로고    scopus 로고
    • Diagnosis and prognosis in acute myeloid leukemia-the art of distinction
    • Lowenberg B. Diagnosis and prognosis in acute myeloid leukemia-the art of distinction. N Engl J Med. 2008;358(18):1960-2.
    • (2008) N Engl J Med , vol.358 , Issue.18 , pp. 1960-1962
    • Lowenberg, B.1
  • 24
    • 0032188805 scopus 로고    scopus 로고
    • The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties
    • Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92(7):2322-33.
    • (1998) Blood , vol.92 , Issue.7 , pp. 2322-2333
    • Grimwade, D.1    Walker, H.2    Oliver, F.3
  • 25
    • 55549101623 scopus 로고    scopus 로고
    • DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
    • Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008;456(7218):66-72.
    • (2008) Nature , vol.456 , Issue.7218 , pp. 66-72
    • Ley, T.J.1    Mardis, E.R.2    Ding, L.3
  • 26
    • 42949083345 scopus 로고    scopus 로고
    • MicroRNA expression in cytogenetically normal acute myeloid leukemia
    • Marcucci G, Radmacher MD, Maharry K, et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358(18):1919-28.
    • (2008) N Engl J Med , vol.358 , Issue.18 , pp. 1919-1928
    • Marcucci, G.1    Radmacher, M.D.2    Maharry, K.3
  • 27
    • 42949142189 scopus 로고    scopus 로고
    • Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
    • Schlenk RF, Dohner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358(18):1909-18.
    • (2008) N Engl J Med , vol.358 , Issue.18 , pp. 1909-1918
    • Schlenk, R.F.1    Dohner, K.2    Krauter, J.3
  • 28
    • 0036786901 scopus 로고    scopus 로고
    • The World Health Organization (WHO) classification of the myeloid neoplasms
    • Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292-302.
    • (2002) Blood , vol.100 , Issue.7 , pp. 2292-2302
    • Vardiman, J.W.1    Harris, N.L.2    Brunning, R.D.3
  • 30
    • 0017653321 scopus 로고
    • Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage
    • Fialkow PJ, Jacobson RJ, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med. 1977;63(1):125-30.
    • (1977) Am J Med , vol.63 , Issue.1 , pp. 125-130
    • Fialkow, P.J.1    Jacobson, R.J.2    Papayannopoulou, T.3
  • 31
    • 84861839077 scopus 로고    scopus 로고
    • Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
    • Huang X, Cortes J, Kantarjian H. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Cancer. 2012;118: 3123-7.
    • (2012) Cancer , vol.118 , pp. 3123-3127
    • Huang, X.1    Cortes, J.2    Kantarjian, H.3
  • 32
    • 78049528573 scopus 로고    scopus 로고
    • Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: The prospective, multicentre Stop Imatinib (STIM) trial
    • Mahon FX, Rea D, Guilhot J, et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol. 2010;11(11):1029-35.
    • (2010) Lancet Oncol , vol.11 , Issue.11 , pp. 1029-1035
    • Mahon, F.X.1    Rea, D.2    Guilhot, J.3
  • 33
    • 84859643082 scopus 로고    scopus 로고
    • Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms
    • Deshpande A, Reddy MM, Schade GO, et al. Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms. Leukemia. 2012;26:708-15.
    • (2012) Leukemia , vol.26 , pp. 708-715
    • Deshpande, A.1    Reddy, M.M.2    Schade, G.O.3
  • 34
    • 79959463542 scopus 로고    scopus 로고
    • Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia
    • van Delft FW, Horsley S, Colman S, et al. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia. Blood. 2011;117:6247-54.
    • (2011) Blood , vol.117 , pp. 6247-6254
    • van Delft, F.W.1    Horsley, S.2    Colman, S.3
  • 35
    • 78751644099 scopus 로고    scopus 로고
    • Genetic variegation of clonal architecture and propagating cells in leukaemia
    • Anderson K, Lutz C, van Delft FW, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature. 2011;469(7330):356-61.
    • (2011) Nature , vol.469 , Issue.7330 , pp. 356-361
    • Anderson, K.1    Lutz, C.2    van Delft, F.W.3
  • 36
    • 78751661556 scopus 로고    scopus 로고
    • Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells
    • Notta F, Mullighan CG, Wang JC, et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature. 2011;469(7330):362-7.
    • (2011) Nature , vol.469 , Issue.7330 , pp. 362-367
    • Notta, F.1    Mullighan, C.G.2    Wang, J.C.3
  • 37
    • 0242361142 scopus 로고    scopus 로고
    • Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia
    • Chessells JM, Veys P, Kempski H, et al. Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. Br J Haematol. 2003;123(3):396-405.
    • (2003) Br J Haematol , vol.123 , Issue.3 , pp. 396-405
    • Chessells, J.M.1    Veys, P.2    Kempski, H.3
  • 38
    • 33846242910 scopus 로고    scopus 로고
    • Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia
    • Cox CV, Martin HM, Kearns PR, et al. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood. 2007;109(2):674-82.
    • (2007) Blood , vol.109 , Issue.2 , pp. 674-682
    • Cox, C.V.1    Martin, H.M.2    Kearns, P.R.3
  • 39
    • 5044225888 scopus 로고    scopus 로고
    • Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
    • Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306(5694):269-71.
    • (2004) Science , vol.306 , Issue.5694 , pp. 269-271
    • Weng, A.P.1    Ferrando, A.A.2    Lee, W.3
  • 40
    • 34547780475 scopus 로고    scopus 로고
    • FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors
    • O'Neil J, Grim J, Strack P, et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med. 2007;204(8):1813-24.
    • (2007) J Exp Med , vol.204 , Issue.8 , pp. 1813-1824
    • O'Neil, J.1    Grim, J.2    Strack, P.3
  • 41
    • 78650333573 scopus 로고    scopus 로고
    • NOTCH mutations as prognostic markers in T-ALL
    • Ferrando A. NOTCH mutations as prognostic markers in T-ALL. Leukemia. 2010;24(12):2003-4.
    • (2010) Leukemia , vol.24 , Issue.12 , pp. 2003-2004
    • Ferrando, A.1
  • 42
    • 70449671729 scopus 로고    scopus 로고
    • Direct inhibition of the NOTCH transcription factor complex
    • Moellering RE, Cornejo M, Davis TN, et al. Direct inhibition of the NOTCH transcription factor complex. Nature. 2009;462(7270):182-8.
    • (2009) Nature , vol.462 , Issue.7270 , pp. 182-188
    • Moellering, R.E.1    Cornejo, M.2    Davis, T.N.3
  • 43
    • 78650068497 scopus 로고    scopus 로고
    • Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance
    • Chiu PP, Jiang H, Dick JE. Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance. Blood. 2010;116(24):5268-79.
    • (2010) Blood , vol.116 , Issue.24 , pp. 5268-5279
    • Chiu, P.P.1    Jiang, H.2    Dick, J.E.3
  • 44
    • 84863088013 scopus 로고    scopus 로고
    • NOTCH1 signaling drives human T-cell acute lymphoblastic leukemia initiating cell survival and self-renewal
    • Ma W, Gutierrez A, Goff DJ, et al. NOTCH1 signaling drives human T-cell acute lymphoblastic leukemia initiating cell survival and self-renewal. PLoS One. 2012;7:e39725.
    • (2012) PLoS One , vol.7 , pp. e39725
    • Ma, W.1    Gutierrez, A.2    Goff, D.J.3
  • 45
    • 77956331142 scopus 로고    scopus 로고
    • Notch signaling in the regulation of stem cell self-renewal and differentiation
    • Liu J, Sato C, Cerletti M, Wagers A. Notch signaling in the regulation of stem cell self-renewal and differentiation. Curr Top Dev Biol. 2010;92:367-409.
    • (2010) Curr Top Dev Biol , vol.92 , pp. 367-409
    • Liu, J.1    Sato, C.2    Cerletti, M.3    Wagers, A.4
  • 46
    • 13944261231 scopus 로고    scopus 로고
    • Rejuvenation of aged progenitor cells by exposure to a young systemic environment
    • Conboy IM, Conboy MJ, Wagers AJ, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433(7027):760-4.
    • (2005) Nature , vol.433 , Issue.7027 , pp. 760-764
    • Conboy, I.M.1    Conboy, M.J.2    Wagers, A.J.3
  • 47
    • 20144370145 scopus 로고    scopus 로고
    • Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance
    • Duncan AW, Rattis FM, DiMascio LN, et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol. 2005;6(3):314-22.
    • (2005) Nat Immunol , vol.6 , Issue.3 , pp. 314-322
    • Duncan, A.W.1    Rattis, F.M.2    DiMascio, L.N.3
  • 48
    • 0037737728 scopus 로고    scopus 로고
    • A role for Wnt signalling in self-renewal of haematopoietic stem cells
    • Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003;423(6938):409-14.
    • (2003) Nature , vol.423 , Issue.6938 , pp. 409-414
    • Reya, T.1    Duncan, A.W.2    Ailles, L.3
  • 49
    • 10244224027 scopus 로고    scopus 로고
    • Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood
    • Haddad R, Guardiola P, Izac B, et al. Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood. Blood. 2004;104(13):3918-26.
    • (2004) Blood , vol.104 , Issue.13 , pp. 3918-3926
    • Haddad, R.1    Guardiola, P.2    Izac, B.3
  • 50
    • 77449121923 scopus 로고    scopus 로고
    • Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells
    • Butler JM, Nolan DJ, Vertes EL, et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell. 2010;6(3):251-64.
    • (2010) Cell Stem Cell , vol.6 , Issue.3 , pp. 251-264
    • Butler, J.M.1    Nolan, D.J.2    Vertes, E.L.3
  • 51
    • 79952217210 scopus 로고    scopus 로고
    • Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells
    • Varnum-Finney B, Halasz LM, Sun M, et al. Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells. J Clin Invest. 2011;121(3):1207-16.
    • (2011) J Clin Invest , vol.121 , Issue.3 , pp. 1207-1216
    • Varnum-finney, B.1    Halasz, L.M.2    Sun, M.3
  • 52
    • 84855370035 scopus 로고    scopus 로고
    • SF3B1 and other novel cancer genes in chronic lymphocytic leukemia
    • Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011;365(26):2497-506.
    • (2011) N Engl J Med , vol.365 , Issue.26 , pp. 2497-2506
    • Wang, L.1    Lawrence, M.S.2    Wan, Y.3
  • 53
    • 46749145421 scopus 로고    scopus 로고
    • CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment
    • Patten PE, Buggins AG, Richards J, et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood. 2008;111(10):5173-81.
    • (2008) Blood , vol.111 , Issue.10 , pp. 5173-5181
    • Patten, P.E.1    Buggins, A.G.2    Richards, J.3
  • 54
    • 77957366071 scopus 로고    scopus 로고
    • Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription
    • Buggins AG, Pepper C, Patten PE, et al. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription. Cancer Res. 2010;70(19):7523-33.
    • (2010) Cancer Res , vol.70 , Issue.19 , pp. 7523-7533
    • Buggins, A.G.1    Pepper, C.2    Patten, P.E.3
  • 55
    • 0028947580 scopus 로고
    • Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice
    • Skoda RC, Tsai SF, Orkin SH, Leder P. Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice. J Exp Med. 1995;181(5):1603-13.
    • (1995) J Exp Med , vol.181 , Issue.5 , pp. 1603-1613
    • Skoda, R.C.1    Tsai, S.F.2    Orkin, S.H.3    Leder, P.4
  • 56
    • 0022380768 scopus 로고
    • The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
    • Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985;318(6046):533-8.
    • (1985) Nature , vol.318 , Issue.6046 , pp. 533-538
    • Adams, J.M.1    Harris, A.W.2    Pinkert, C.A.3
  • 57
    • 33646339095 scopus 로고    scopus 로고
    • MYC levels govern hematopoietic tumor type and latency in transgenic mice
    • Smith DP, Bath ML, Metcalf D, et al. MYC levels govern hematopoietic tumor type and latency in transgenic mice. Blood. 2006;108(2):653-61.
    • (2006) Blood , vol.108 , Issue.2 , pp. 653-661
    • Smith, D.P.1    Bath, M.L.2    Metcalf, D.3
  • 58
    • 79952830167 scopus 로고    scopus 로고
    • Myc roles in hematopoiesis and leukemia
    • Delgado MD, Leon J. Myc roles in hematopoiesis and leukemia. Genes Cancer. 2010;1(6):605-16.
    • (2010) Genes Cancer , vol.1 , Issue.6 , pp. 605-616
    • Delgado, M.D.1    Leon, J.2
  • 59
    • 67649861052 scopus 로고    scopus 로고
    • Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia
    • Chen Y, Hu Y, Zhang H, et al. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet. 2009;41(7):783-92.
    • (2009) Nat Genet , vol.41 , Issue.7 , pp. 783-792
    • Chen, Y.1    Hu, Y.2    Zhang, H.3
  • 60
    • 33646546386 scopus 로고    scopus 로고
    • The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
    • Jamieson CH, Gotlib J, Durocher JA, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103(16):6224-9.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , Issue.16 , pp. 6224-6229
    • Jamieson, C.H.1    Gotlib, J.2    Durocher, J.A.3
  • 61
    • 79952437988 scopus 로고    scopus 로고
    • Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia
    • Samanta A, Perazzona B, Chakraborty S, et al. Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia. Leukemia. 2011;25(3):463-72.
    • (2011) Leukemia , vol.25 , Issue.3 , pp. 463-472
    • Samanta, A.1    Perazzona, B.2    Chakraborty, S.3
  • 62
    • 84859865097 scopus 로고    scopus 로고
    • Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice
    • Walz C, Ahmed W, Lazarides K, et al. Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice. Blood. 2012;119(15):3550-60.
    • (2012) Blood , vol.119 , Issue.15 , pp. 3550-3560
    • Walz, C.1    Ahmed, W.2    Lazarides, K.3
  • 63
    • 84864567410 scopus 로고    scopus 로고
    • Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
    • Tanaka S, Miyagi S, Sashida G, et al. Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia. Blood. 2012;120:1107-17.
    • (2012) Blood , vol.120 , pp. 1107-1117
    • Tanaka, S.1    Miyagi, S.2    Sashida, G.3
  • 64
    • 77950287628 scopus 로고    scopus 로고
    • The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML
    • Wang Y, Krivtsov AV, Sinha AU, et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science. 2010;327(5973):1650-3.
    • (2010) Science , vol.327 , Issue.5973 , pp. 1650-1653
    • Wang, Y.1    Krivtsov, A.V.2    Sinha, A.U.3
  • 65
    • 20844463226 scopus 로고    scopus 로고
    • Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli
    • Holtz MS, Forman SJ, Bhatia R. Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia. 2005;19(6):1034-41.
    • (2005) Leukemia , vol.19 , Issue.6 , pp. 1034-1041
    • Holtz, M.S.1    Forman, S.J.2    Bhatia, R.3
  • 66
    • 33744486584 scopus 로고    scopus 로고
    • Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
    • Copland M, Hamilton A, Elrick LJ, et al. Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood. 2006;107(11):4532-9.
    • (2006) Blood , vol.107 , Issue.11 , pp. 4532-4539
    • Copland, M.1    Hamilton, A.2    Elrick, L.J.3
  • 67
    • 0037421968 scopus 로고    scopus 로고
    • Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo
    • Karnauskas R, Niu Q, Talapatra S, et al. Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo. Oncogene. 2003;22(5):688-98.
    • (2003) Oncogene , vol.22 , Issue.5 , pp. 688-698
    • Karnauskas, R.1    Niu, Q.2    Talapatra, S.3
  • 68
    • 0345144023 scopus 로고    scopus 로고
    • High levels of BAX, low levels of MRP-1, and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML
    • Lange T, Gunther C, Kohler T, et al. High levels of BAX, low levels of MRP-1, and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML. Blood. 2003;101(6):2152-5.
    • (2003) Blood , vol.101 , Issue.6 , pp. 2152-2155
    • Lange, T.1    Gunther, C.2    Kohler, T.3
  • 69
    • 84861385403 scopus 로고    scopus 로고
    • Scd1 plays a tumor-suppressive role in survival of leukemia stem cells and the development of chronic myeloid leukemia
    • Zhang H, Li H, Ho N, et al. Scd1 plays a tumor-suppressive role in survival of leukemia stem cells and the development of chronic myeloid leukemia. Mol Cell Biol. 2012;32(10):1776-87.
    • (2012) Mol Cell Biol , vol.32 , Issue.10 , pp. 1776-1787
    • Zhang, H.1    Li, H.2    Ho, N.3
  • 70
    • 84862777672 scopus 로고    scopus 로고
    • A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
    • Ng KP, Hillmer AM, Chuah CT, et al. A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer. Nat Med. 2012;18(4):521-8.
    • (2012) Nat Med , vol.18 , Issue.4 , pp. 521-528
    • Ng, K.P.1    Hillmer, A.M.2    Chuah, C.T.3
  • 71
    • 0036153470 scopus 로고    scopus 로고
    • High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML)
    • Kohler T, Schill C, Deininger MW, et al. High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML). Leukemia. 2002;16(1):22-9.
    • (2002) Leukemia , vol.16 , Issue.1 , pp. 22-29
    • Kohler, T.1    Schill, C.2    Deininger, M.W.3
  • 72
    • 16444375702 scopus 로고    scopus 로고
    • Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia
    • Packham G, Stevenson FK. Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology. 2005;114(4):441-9.
    • (2005) Immunology , vol.114 , Issue.4 , pp. 441-449
    • Packham, G.1    Stevenson, F.K.2
  • 73
    • 55749105701 scopus 로고    scopus 로고
    • Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
    • Pepper C, Lin TT, Pratt G, et al. Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood. 2008;112(9):3807-17.
    • (2008) Blood , vol.112 , Issue.9 , pp. 3807-3817
    • Pepper, C.1    Lin, T.T.2    Pratt, G.3
  • 74
    • 20044372326 scopus 로고    scopus 로고
    • In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells
    • Messmer BT, Messmer D, Allen SL, et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest. 2005;115(3):755-64.
    • (2005) J Clin Invest , vol.115 , Issue.3 , pp. 755-764
    • Messmer, B.T.1    Messmer, D.2    Allen, S.L.3
  • 75
    • 84865861478 scopus 로고    scopus 로고
    • Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia
    • Billard C. Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia. Leukemia. 2012;26:2032-8.
    • (2012) Leukemia , vol.26 , pp. 2032-2038
    • Billard, C.1
  • 76
    • 33644525274 scopus 로고    scopus 로고
    • Gene expression changes associated with progression and response in chronic myeloid leukemia
    • Radich JP, Dai H, Mao M, et al. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci U S A. 2006;103(8):2794-9.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , Issue.8 , pp. 2794-2799
    • Radich, J.P.1    Dai, H.2    Mao, M.3
  • 77
    • 36649002031 scopus 로고    scopus 로고
    • Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo
    • Zhao C, Blum J, Chen A, et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell. 2007;12(6):528-41.
    • (2007) Cancer Cell , vol.12 , Issue.6 , pp. 528-541
    • Zhao, C.1    Blum, J.2    Chen, A.3
  • 78
    • 50649118068 scopus 로고    scopus 로고
    • Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation
    • Dierks C, Beigi R, Guo GR, et al. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell. 2008;14(3):238-49.
    • (2008) Cancer Cell , vol.14 , Issue.3 , pp. 238-249
    • Dierks, C.1    Beigi, R.2    Guo, G.R.3
  • 79
    • 64749091867 scopus 로고    scopus 로고
    • Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
    • Zhao C, Chen A, Jamieson CH, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature. 2009;458(7239):776-9.
    • (2009) Nature , vol.458 , Issue.7239 , pp. 776-779
    • Zhao, C.1    Chen, A.2    Jamieson, C.H.3
  • 80
    • 56649114489 scopus 로고    scopus 로고
    • BCR-ABL-transformed GMP as myeloid leukemic stem cells
    • Minami Y, Stuart SA, Ikawa T, et al. BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proc Natl Acad Sci U S A. 2008;105(46):17967-72.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , Issue.46 , pp. 17967-17972
    • Minami, Y.1    Stuart, S.A.2    Ikawa, T.3
  • 81
    • 33947267129 scopus 로고    scopus 로고
    • Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells
    • Moore MA, Dorn DC, Schuringa JJ, et al. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Exp Hematol. 2007;35(4 Suppl 1): 105-16.
    • (2007) Exp Hematol , vol.35 , pp. 105-116
    • Moore, M.A.1    Dorn, D.C.2    Schuringa, J.J.3
  • 82
    • 0026504525 scopus 로고
    • Homeobox genes and axial patterning
    • McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell. 1992;68(2):283-302.
    • (1992) Cell , vol.68 , Issue.2 , pp. 283-302
    • McGinnis, W.1    Krumlauf, R.2
  • 83
    • 0030942488 scopus 로고    scopus 로고
    • Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis
    • Lawrence HJ, Helgason CD, Sauvageau G, et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood. 1997;89(6):1922-30.
    • (1997) Blood , vol.89 , Issue.6 , pp. 1922-1930
    • Lawrence, H.J.1    Helgason, C.D.2    Sauvageau, G.3
  • 84
    • 79959899727 scopus 로고    scopus 로고
    • Hox transcription factor regulation of adult bone-marrow-derived cell behaviour during tissue repair and regeneration
    • Mahdipour E, Mace KA. Hox transcription factor regulation of adult bone-marrow-derived cell behaviour during tissue repair and regeneration. Expert Opin Biol Ther. 2011;11(8):1079-90.
    • (2011) Expert Opin Biol Ther , vol.11 , Issue.8 , pp. 1079-1090
    • Mahdipour, E.1    Mace, K.A.2
  • 85
    • 0037673984 scopus 로고    scopus 로고
    • Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
    • Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 2003;423(6937):255-60.
    • (2003) Nature , vol.423 , Issue.6937 , pp. 255-260
    • Lessard, J.1    Sauvageau, G.2
  • 86
    • 79957839752 scopus 로고    scopus 로고
    • Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells
    • Smith LL, Yeung J, Zeisig BB, et al. Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells. Cell Stem Cell. 2011;8(6):649-62.
    • (2011) Cell Stem Cell , vol.8 , Issue.6 , pp. 649-662
    • Smith, L.L.1    Yeung, J.2    Zeisig, B.B.3
  • 87
    • 79958083987 scopus 로고    scopus 로고
    • Notch-ing from T-cell to B-cell lymphoid malignancies
    • Mirandola L, Comi P, Cobos E, et al. Notch-ing from T-cell to B-cell lymphoid malignancies. Cancer Lett. 2011;308(1):1-13.
    • (2011) Cancer Lett , vol.308 , Issue.1 , pp. 1-13
    • Mirandola, L.1    Comi, P.2    Cobos, E.3
  • 88
    • 79956319072 scopus 로고    scopus 로고
    • Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies
    • Treanor LM, Volanakis EJ, Zhou S, et al. Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies. Blood. 2011;117(20):5453-62.
    • (2011) Blood , vol.117 , Issue.20 , pp. 5453-5462
    • Treanor, L.M.1    Volanakis, E.J.2    Zhou, S.3
  • 89
    • 35448967331 scopus 로고    scopus 로고
    • Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia
    • Apperley JF. Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia. Lancet Oncol. 2007;8(11):1018-29.
    • (2007) Lancet Oncol , vol.8 , Issue.11 , pp. 1018-1029
    • Apperley, J.F.1
  • 90
    • 77954219134 scopus 로고    scopus 로고
    • The bone marrow microenvironment as a sanctuary for minimal residual disease in CML
    • Nair RR, Tolentino J, Hazlehurst LA. The bone marrow microenvironment as a sanctuary for minimal residual disease in CML. Biochem Pharmacol. 2010;80(5):602-12.
    • (2010) Biochem Pharmacol , vol.80 , Issue.5 , pp. 602-612
    • Nair, R.R.1    Tolentino, J.2    Hazlehurst, L.A.3
  • 91
    • 0033568250 scopus 로고    scopus 로고
    • Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia
    • Holyoake T, Jiang X, Eaves C, Eaves A. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood. 1999;94(6):2056-64.
    • (1999) Blood , vol.94 , Issue.6 , pp. 2056-2064
    • Holyoake, T.1    Jiang, X.2    Eaves, C.3    Eaves, A.4
  • 92
    • 35948984135 scopus 로고    scopus 로고
    • Chemotherapy-resistant human AML stem cells home to and engraft within the bonemarrow endosteal region
    • Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bonemarrow endosteal region. Nat Biotechnol. 2007;25(11):1315-21.
    • (2007) Nat Biotechnol , vol.25 , Issue.11 , pp. 1315-1321
    • Ishikawa, F.1    Yoshida, S.2    Saito, Y.3
  • 93
    • 0036090222 scopus 로고    scopus 로고
    • Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
    • Graham SM, Jorgensen HG, Allan E, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002;99(1):319-25.
    • (2002) Blood , vol.99 , Issue.1 , pp. 319-325
    • Graham, S.M.1    Jorgensen, H.G.2    Allan, E.3
  • 94
    • 84862286978 scopus 로고    scopus 로고
    • Significance of CD44 and CD24 as cancer stem cell markers: An enduring ambiguity
    • Jaggupilli A, Elkord E. Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity. Clin Dev Immunol. 2012;2012:708036.
    • (2012) Clin Dev Immunol , vol.2012 , pp. 708036
    • Jaggupilli, A.1    Elkord, E.2
  • 95
    • 33749521890 scopus 로고    scopus 로고
    • Requirement for CD44 in homing and engraftment of BCR-ABL- expressing leukemic stem cells
    • Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Requirement for CD44 in homing and engraftment of BCR-ABL- expressing leukemic stem cells. Nat Med. 2006;12(10):1175-80.
    • (2006) Nat Med , vol.12 , Issue.10 , pp. 1175-1180
    • Krause, D.S.1    Lazarides, K.2    von Andrian, U.H.3    Van Etten, R.A.4
  • 96
    • 33749515476 scopus 로고    scopus 로고
    • Targeting of CD44 eradicates human acute myeloid leukemic stem cells
    • Jin L, Hope KJ, Zhai Q, et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006;12(10):1167-74.
    • (2006) Nat Med , vol.12 , Issue.10 , pp. 1167-1174
    • Jin, L.1    Hope, K.J.2    Zhai, Q.3
  • 97
    • 42249103574 scopus 로고    scopus 로고
    • CXCR4 is required for the quiescence of primitive hematopoietic cells
    • Nie Y, Han YC, Zou YR. CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med. 2008;205(4):777-83.
    • (2008) J Exp Med , vol.205 , Issue.4 , pp. 777-783
    • Nie, Y.1    Han, Y.C.2    Zou, Y.R.3
  • 98
    • 33845445939 scopus 로고    scopus 로고
    • Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches
    • Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006;25(6):977-88.
    • (2006) Immunity , vol.25 , Issue.6 , pp. 977-988
    • Sugiyama, T.1    Kohara, H.2    Noda, M.3    Nagasawa, T.4
  • 99
    • 84860767803 scopus 로고    scopus 로고
    • Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib
    • Weisberg E, Azab AK, Manley PW, et al. Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib. Leukemia. 2012;26:985-90.
    • (2012) Leukemia , vol.26 , pp. 985-990
    • Weisberg, E.1    Azab, A.K.2    Manley, P.W.3
  • 100
    • 38349086394 scopus 로고    scopus 로고
    • CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells
    • Jin L, Tabe Y, Konoplev S, et al. CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Mol Cancer Ther. 2008;7(1):48-58.
    • (2008) Mol Cancer Ther , vol.7 , Issue.1 , pp. 48-58
    • Jin, L.1    Tabe, Y.2    Konoplev, S.3
  • 101
    • 84255197306 scopus 로고    scopus 로고
    • Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: Longterm observation of 1151 patients from the randomized CML Study IV
    • Fabarius A, Leitner A, Hochhaus A, et al. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: longterm observation of 1151 patients from the randomized CML Study IV. Blood. 2011;118(26):6760-8.
    • (2011) Blood , vol.118 , Issue.26 , pp. 6760-6768
    • Fabarius, A.1    Leitner, A.2    Hochhaus, A.3
  • 102
    • 84872757839 scopus 로고    scopus 로고
    • New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing
    • Domenech E, Gomez-Lopez G, Gzlez-Pena D, et al. New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing. PLoS One. 2012;7(6):e38158.
    • (2012) PLoS One , vol.7 , Issue.6 , pp. e38158
    • Domenech, E.1    Gomez-lopez, G.2    Gzlez-pena, D.3
  • 103
    • 84863116398 scopus 로고    scopus 로고
    • Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia
    • Marcucci G, Metzeler KH, Schwind S, et al. Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. J Clin Oncol. 2012;30(7):742-50.
    • (2012) J Clin Oncol , vol.30 , Issue.7 , pp. 742-750
    • Marcucci, G.1    Metzeler, K.H.2    Schwind, S.3
  • 104
    • 84859837026 scopus 로고    scopus 로고
    • The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells
    • Harris WJ, Huang X, Lynch JT, et al. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell. 2012;21(4):473-87.
    • (2012) Cancer Cell , vol.21 , Issue.4 , pp. 473-487
    • Harris, W.J.1    Huang, X.2    Lynch, J.T.3
  • 106
    • 33748451151 scopus 로고    scopus 로고
    • Anticancer activities of histone deacetylase inhibitors
    • Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006;5(9):769-84.
    • (2006) Nat Rev Drug Discov , vol.5 , Issue.9 , pp. 769-784
    • Bolden, J.E.1    Peart, M.J.2    Johnstone, R.W.3
  • 107
    • 77952105211 scopus 로고    scopus 로고
    • Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate
    • Zhang B, Strauss AC, Chu S, et al. Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell. 2010;17(5):427-42.
    • (2010) Cancer Cell , vol.17 , Issue.5 , pp. 427-442
    • Zhang, B.1    Strauss, A.C.2    Chu, S.3
  • 108
    • 84863011183 scopus 로고    scopus 로고
    • Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib
    • Li L, Wang L, Li L, et al. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell. 2012;21(2):266-81.
    • (2012) Cancer Cell , vol.21 , Issue.2 , pp. 266-281
    • Li, L.1    Wang, L.2    Li, L.3
  • 109
    • 80054777860 scopus 로고    scopus 로고
    • Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors
    • Paquette RL, Nicoll J, Chalukya M, et al. Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors. Cancer Genet. 2011;204(7):392-7.
    • (2011) Cancer Genet , vol.204 , Issue.7 , pp. 392-397
    • Paquette, R.L.1    Nicoll, J.2    Chalukya, M.3
  • 110
    • 84876675153 scopus 로고    scopus 로고
    • Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription
    • Maicas M, Vazquez I, Vicente C, et al. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription. Oncogene. 2013;32:2069-78.
    • (2013) Oncogene , vol.32 , pp. 2069-2078
    • Maicas, M.1    Vazquez, I.2    Vicente, C.3
  • 111
    • 84870437993 scopus 로고    scopus 로고
    • RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with poor prognosis and up-regulation of lymphoid genes
    • Greif PA, Konstandin NP, Metzeler KH, et al. RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with poor prognosis and up-regulation of lymphoid genes. Haematologica. 2012;97:1909-15.
    • (2012) Haematologica , vol.97 , pp. 1909-1915
    • Greif, P.A.1    Konstandin, N.P.2    Metzeler, K.H.3
  • 112
    • 81555228423 scopus 로고    scopus 로고
    • Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
    • Shen Y, Zhu YM, Fan X, et al. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood. 2011;118(20):5593-603.
    • (2011) Blood , vol.118 , Issue.20 , pp. 5593-5603
    • Shen, Y.1    Zhu, Y.M.2    Fan, X.3
  • 113
    • 84864031521 scopus 로고    scopus 로고
    • Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia
    • Akalin A, Garrett-Bakelman FE, Kormaksson M, et al. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia. PLoS Genet. 2012;8(6):e1002781.
    • (2012) PLoS Genet , vol.8 , Issue.6 , pp. e1002781
    • Akalin, A.1    Garrett-bakelman, F.E.2    Kormaksson, M.3
  • 114
    • 80052284526 scopus 로고    scopus 로고
    • Ten-eleven-translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
    • Ko M, Bandukwala HS, An J, et al. Ten-eleven-translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc Natl Acad Sci U S A. 2011;108(35):14566-71.
    • (2011) Proc Natl Acad Sci U S A , vol.108 , Issue.35 , pp. 14566-14571
    • Ko, M.1    Bandukwala, H.S.2    An, J.3
  • 115
    • 2342565860 scopus 로고    scopus 로고
    • p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells
    • Salesse S, Dylla SJ, Verfaillie CM. p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells. Leukemia. 2004;18(4):727-33.
    • (2004) Leukemia , vol.18 , Issue.4 , pp. 727-733
    • Salesse, S.1    Dylla, S.J.2    Verfaillie, C.M.3
  • 116
    • 84875131206 scopus 로고    scopus 로고
    • A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition
    • Goff DJ, Recart AC, Sadarangani A, et al. A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition. Cell Stem Cell. 2013;12(3):316-28.
    • (2013) Cell Stem Cell , vol.12 , Issue.3 , pp. 316-328
    • Goff, D.J.1    Recart, A.C.2    Sadarangani, A.3
  • 117
    • 84555191727 scopus 로고    scopus 로고
    • Spliceosome mutations in hematopoietic malignancies
    • Hahn CN, Scott HS. Spliceosome mutations in hematopoietic malignancies. Nat Genet. 2012;44(1):9-10.
    • (2012) Nat Genet , vol.44 , Issue.1 , pp. 9-10
    • Hahn, C.N.1    Scott, H.S.2
  • 119
    • 84555171449 scopus 로고    scopus 로고
    • Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
    • Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet. 2012;44(1):47-52.
    • (2012) Nat Genet , vol.44 , Issue.1 , pp. 47-52
    • Quesada, V.1    Conde, L.2    Villamor, N.3
  • 120
    • 84862854953 scopus 로고    scopus 로고
    • Chronic lymphocytic leukemia with SF3B1 mutation
    • Quesada V, Ramsay AJ, Lopez-Otin C. Chronic lymphocytic leukemia with SF3B1 mutation. N Engl J Med. 2012;366(26):2530.
    • (2012) N Engl J Med , vol.366 , Issue.26 , pp. 2530
    • Quesada, V.1    Ramsay, A.J.2    Lopez-otin, C.3
  • 121
    • 57849136005 scopus 로고    scopus 로고
    • ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling
    • Hartner JC, Walkley CR, Lu J, Orkin SH. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol. 2009;10(1):109-15.
    • (2009) Nat Immunol , vol.10 , Issue.1 , pp. 109-115
    • Hartner, J.C.1    Walkley, C.R.2    Lu, J.3    Orkin, S.H.4
  • 122
    • 70449584569 scopus 로고    scopus 로고
    • ADAR1 is required for hematopoietic progenitor cell survival via RNA editing
    • XuFeng R, Boyer MJ, Shen H, et al. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc Natl Acad Sci U S A. 2009;106(42):17763-8.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , Issue.42 , pp. 17763-17768
    • XuFeng, R.1    Boyer, M.J.2    Shen, H.3
  • 123
    • 70349969478 scopus 로고    scopus 로고
    • Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
    • Shah SP, Morin RD, Khattra J, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 2009;461(7265):809-13.
    • (2009) Nature , vol.461 , Issue.7265 , pp. 809-813
    • Shah, S.P.1    Morin, R.D.2    Khattra, J.3
  • 124
    • 84872522380 scopus 로고    scopus 로고
    • ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia
    • Jiang Q, Crews LA, Barrett CL, et al. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. Proc Natl Acad Sci U S A. 2013;110(3):1041-6.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , Issue.3 , pp. 1041-1046
    • Jiang, Q.1    Crews, L.A.2    Barrett, C.L.3
  • 125
    • 84873996576 scopus 로고    scopus 로고
    • Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice
    • Steinman RA, Yang Q, Gasparetto M, et al. Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice. Int J Cancer. 2013;132(8):1741-50.
    • (2013) Int J Cancer , vol.132 , Issue.8 , pp. 1741-1750
    • Steinman, R.A.1    Yang, Q.2    Gasparetto, M.3
  • 126
    • 84862649489 scopus 로고    scopus 로고
    • Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons
    • Meyer KD, Saletore Y, Zumbo P, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell. 2012;149(7):1635-46.
    • (2012) Cell , vol.149 , Issue.7 , pp. 1635-1646
    • Meyer, K.D.1    Saletore, Y.2    Zumbo, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.